Buch, Englisch, 490 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 1020 g
Volume 20
Buch, Englisch, 490 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 1020 g
ISBN: 978-0-12-816422-8
Verlag: Elsevier Health Sciences
A concluding chapter brings together future perspectives for targeting histone modifications in therapy and next steps in research.
Zielgruppe
<p>Clinician-scientists; Human Geneticists; Medical Geneticists; Researchers working in genetics, biology, molecular biology, pharmaceutical science, oncology, cardiology, psychiatry, neurology, neuroscience, metabolic disorders, inflammatory and infectious disease, internal medicine, and clinical therapy; advanced undergraduate students, graduate students; pharmaceutical company and biotechnology researchers interested in drug development and therapies </p>
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik
- Naturwissenschaften Biowissenschaften Molekularbiologie
- Naturwissenschaften Biowissenschaften Biowissenschaften Genetik und Genomik (nichtmedizinisch)
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
- Naturwissenschaften Biowissenschaften Biowissenschaften DNA und Transgene Organismen
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
Weitere Infos & Material
1. Histone modifications in diseases
Section I Targeting histone modifications for cancer treatment 2. HDAC inhibitors in cancer therapy 3. HAT inhibitors in cancer therapy 4. Targeting DOT1L for mixed-lineage rearranged leukemia 5. BET mechanisms in cancer 6. Histone demethylase inhibitors and their potential in cancer treatment 7. Targeting chromatin remodelers in urological tumors
Section II Targeting histone modifications for infectious disease 8. The therapeutic potential of epigenetic manipulation during infectious diseases 9. Targeting histone deacetylases for bacterial infections 10. Targeting histone epigenetics to control viral infections
Section III Targeting histone modifications for treating other pathologies 11. Targeting histone modifications in psychotic disorders 12. Epigenetic treatment of neurodegenerative diseases 13. Histone modification as a potential preventative and therapeutic approach for cardiovascular disease 14. The potentiality of histone deacetylase inhibitors for diabetes and obesity 15. Targeting histone modifications in cancer immunotherapy 16. Epigenetic drug development for autoimmune and inflammatory diseases 17. Future perspectives for targeting histone modifications in therapy